Abstract
BackgroundMyositis-specific autoantibodies (MSA) are increasingly recognized as important diagnostic and prognostic markers in idiopathic inflammatory myopathies (IIM) (polymyositis, dermatomyositis, sporadic inclusion body myositis and necrotizing autoimmune myositis). The prevalence of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have